Substrate utilization by the failing human heart by direct quantification using arterio-venous blood sampling

PLoS ONE

Volumn 4, Issue 10, 2009, Pages

  Funada, Junichi ^a   Betts, Tim R ^b   Hodson, Leanne ^a   Humphreys, Sandy M ^a   Timperley, Jon ^b   Frayn, Keith N ^a   Karpe, Fredrik ^a,c  

^a CHURCHILL HOSPITAL   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^c NIHR OXFORD BIOMEDICAL RESEARCH CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYBUTYRIC ACID; FATTY ACID; GLUCOSE; GLYCEROL; LACTIC ACID; PALMITIC ACID DERIVATIVE; PYRUVIC ACID; TRIACYLGLYCEROL; OXYGEN;

ADULT; ARTERIAL BLOOD; ARTICLE; BLOOD GAS ANALYSIS; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY SINUS; DISEASE SEVERITY; FATTY ACID BLOOD LEVEL; FATTY ACID TRANSPORT; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEROL BLOOD LEVEL; HEART ELECTROPHYSIOLOGY; HEART FAILURE; HUMAN; LACTATE BLOOD LEVEL; MALE; METABOLITE; NON INSULIN DEPENDENT DIABETES MELLITUS; QUANTITATIVE ANALYSIS; TRIACYLGLYCEROL BLOOD LEVEL; ARTERY; BLOOD; CHEMISTRY; ELECTROCARDIOGRAPHY; ELECTROPHYSIOLOGY; HEART; HEART MUSCLE; METABOLISM; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY;

ADULT; ARTERIES; CORONARY SINUS; DIABETES MELLITUS, TYPE 2; ELECTROCARDIOGRAPHY; ELECTROPHYSIOLOGY; FATTY ACIDS, NONESTERIFIED; FEMALE; HEART; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; MYOCARDIUM; OXYGEN;

EID: 70449591256     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0007533     Document Type: Article

References (14)

1. Ferrannini E, Santoro D, Bonadonna R, Natali A, Parodi O, et al. (1993) Metabolic and hemodynamic effects of insulin on human hearts. Am J Physiol 264: E308-315.
2. Korvald C, Elvenes OP, Myrmel T (2000) Myocardial substrate metabolism influences left ventricular energetics in vivo. Am J Physiol Heart Circ Physiol 278: H1345-1351.
3. Stanley WC, Recchia FA, Lopaschuk GD (2005) Myocardial substrate metabolism in the normal and failing heart. Physiol Rev 85: 1093-1129.
4. Razeghi P, Young ME, Alcorn JL, Moravec CS, Frazier OH, et al. (2001) Metabolic gene expression in fetal and failing human heart. Circulation 104: 2923-2931.
5. Taegtmeyer H, Golfman L, Sharma S, Razeghi P, van Arsdall M (2004) Linking gene expression to function: metabolic flexibility in the normal and diseased heart. Ann N Y Acad Sci 1015: 202-213.
6. Davila-Roman VG, Vedala G, Herrero P, de las Fuentes L, Rogers JG, et al. (2002) Altered myocardial fatty acid and glucose metabolism in idiopathic dilated cardiomyopathy. J Am Coll Cardiol 40: 271-277.
7. Taylor M, Wallhaus TR, Degrado TR, Russell DC, Stanko P, et al. (2001) An evaluation of myocardial fatty acid and glucose uptake using PET with [18F]fluoro-6-thia-heptadecanoic acid and [18F]FDG in Patients with Congestive Heart Failure. J Nucl Med 42: 55-62.
8. Wallhaus TR, Taylor M, DeGrado TR, Russell DC, Stanko P, et al. (2001) Myocardial free fatty acid and glucose use after carvedilol treatment in patients with congestive heart failure. Circulation 103: 2441-2446.
9. Hariharan R, Bray M, Ganim R, Doenst T, Goodwin GW, et al. (1995) Fundamental limitations of [18F]2-deoxy-2-fluoro-D-glucose for assessing myocardial glucose uptake. Circulation 91: 2435-2444.
10. Blain JM, Schafer H, Siegel AL, Bing RJ (1956) Studies on myocardial metabolism. VI. Myocardial metabolism in congestive failure. Am J Med 20: 820-833.
11. Bickerton AS, Roberts R, Fielding BA, Hodson L, Blaak EE, et al. (2007) Preferential uptake of dietary Fatty acids in adipose tissue and muscle in the postprandial period. Diabetes 56: 168-176.
12. Lassers BW, Kaijser L, Carlson LA (1972) Myocardial lipid and carbohydrate metabolism in healthy, fasting men at rest: studies during continuous infusion of 3 H-palmitate. Eur J Clin Invest 2: 348-358.
13. Iacobellis G, Corradi D, Sharma AM (2005) Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart. Nat Clin Pract Cardiovasc Med 2: 536-543.
14. Abozguia K, Clarke K, Lee L, Frenneaux M (2006) Modification of myocardial substrate use as a therapy for heart failure. Nat Clin Pract Cardiovasc Med 3: 490-498.